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Despite the increasing number of obese patients, evidence-based 
dosing guidelines are scarce, particularly for obese children and 
morbidly obese adults (BMI > 40 kg/m2). For both these popula-
tions, pharmacokinetic studies are needed to provide a basis for 
evidence-based dosing guidelines. 
In this thesis, we studied the pharmacokinetics of the CYP3A 
substrate midazolam, the renally excreted drug metformin and 
acetaminophen (metabolized by glucuronidation, sulphation and 
CYP2E1) in obese adolescents and/or morbidly obese adults. We ad-
dress several currently unanswered questions; Can doses for obese 
adolescents be predicted on the basis of data obtained in morbidly 
obese adults? How to analyse pharmacokinetic data in obese ado-
lescents, for whom body weight is infl uenced by growth, age and 
obesity? How to achieve safe and effective acetaminophen dosing 
for morbidly obese patients? 
The studies described in this thesis contribute to the existing gaps 
in knowledge regarding the pharmacokinetics and evidence-based 
dosing of drugs in obese adolescents and morbidly obese adults.
